International Journal of Endocrinology

Volume 2012 (2012), Article ID 872305, 6 pages

doi:10.1155/2012/872305

Research Article

Evaluation of Health-Related Quality of Life according to Carbohydrate Metabolism Status: A Spanish Population-Based Study (Di@bet.es Study)

C. Marcuello,¹ A. L. Calle-Pascual,¹ M. Fuentes,² I. Runkle,¹ F. Soriguer,3,4 A. Goday,⁵ A. Bosch-Comas,3,6 E. Bordiú,⁷ R. Carmena,3,8 R. Casamitjana,3,9 L. Castaño,3,10 C. Castell,¹¹ M. Catalá,3,8 E. Delgado,¹² J. Franch,¹³ S. Gaztambide,3,10 J. Girbés,¹⁴ R. Gomis,3,6,15 G. Gutiérrez,3,10 A. López-Alba,¹⁶ M. T. Martínez-Larrad,3,17 E. Menéndez,¹² I. Mora-Peces,¹⁸ E. Ortega,3,6,15 G. Pascual-Manich,³ G. Rojo-Martínez,3,4 M. Serrano-Rios,3,17 S. Valdés,3,4 J. A. Vázquez,¹⁹ and J. Vendrell3,20

¹Department of Endocrinology and Nutrition, Hospital Clínico San Carlos de Madrid, Profesor Martín Lagos s/n, 28040 Madrid, Spain

²Preventive Medicine Service, Hospital Clínico San Carlos de Madrid, Profesor Martín Lagos s/n, 28040 Madrid, Spain

³Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spain

⁴Department of Endocrinology and Nutrition, Hospital Regional Universitario Carlos Haya Málaga, Málaga, Spain

⁵Department of Endocrinology and Nutrition, Hospital del Mar, 08003 Barcelona, Spain

⁶Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain

⁷Laboratorio de Endocrinología, Hospital Clínico San Carlos de Madrid, 28040 Madrid, Spain

⁸Department of Medicine and Endocrinology, Hospital Clínico Universitario de Valencia, 40010 Valencia, Spain

⁹Biomedic Diagnostic Centre, Hospital Clínic de Barcelona, 08007 Barcelona, Spain

¹⁰Diabetes Research Group, Hospital Universitario de Cruces, UPV-EHU, Barakaldo, Spain

¹¹Public Health Division, Department of Health, Autonomous Government of Catalonia, Barcelona, Spain

¹²Department of Endocrinology and Nutrition, Hospital Central de Asturias, 33006 Oviedo, Spain

¹³EAP Raval Sud, Institut Català de la Salut, Red GEDAPS, Primary Care, Unitat de Suport a la Recerca (IDIAP—Fundació Jordi Gol), Barcelona, Spain

¹⁴Diabetes Unit, Hospital Arnau de Vilanova, 46015 Valencia, Spain

¹⁵Endocrinology and Diabetes Unit, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08007 Barcelona, Spain

¹⁶Spanish Diabetes Society, Madrid, Spain

¹⁷Lipids and Diabetes Laboratory, Hospital Clínico San Carlos de Madrid, Profesor Martín Lagos s/n, 28040 Madrid, Spain

¹⁸Canarian Health Service, Tenerife, Spain

¹⁹Diabetes National Plan, Ministry of Health, Madrid, Spain

²⁰Department of Endocrinology and Nutrition, Hospital Universitario Joan XXIII, Institut d’Investigacions Sanitaries Pere Virgili, Tarragona, Spain

Received 21 February 2012; Revised 7 May 2012; Accepted 22 May 2012

Academic Editor: Daniela Jezova

Copyright © 2012 C. Marcuello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. To evaluate the association between diabetes mellitus and health-related quality of life (HRQOL) controlled for several sociodemographic and anthropometric variables, in a representative sample of the Spanish population. Methods. A population-based, cross-sectional, and cluster sampling study, with the entire Spanish population as the target population. Five thousand and forty-seven participants (2162/2885 men/women) answered the HRQOL short form 12-questionnaire (SF-12). The physical (PCS-12) and the mental component summary (MCS-12) scores were assessed. Subjects were divided into four groups according to carbohydrate metabolism status: normal, prediabetes, unknown diabetes (UNKDM), and known diabetes (KDM). Logistic regression analyses were conducted. Results. Mean PCS-12/MCS-12 values were /, respectively. Men had higher scores than women in both PCS-12 ( versus ; ) and MCS-12 ( versus ; ). Increasing age and obesity were associated with a poorer PCS-12 score. In women lower PCS-12 and MCS-12 scores were associated with a higher level of glucose metabolism abnormality (prediabetes and diabetes), ( for trend), but only the PCS-12 score was associated with altered glucose levels in men ( for trend). The Odds Ratio adjusted for age, body mass index (BMI) and educational level, for a PCS-12 score below the median was 1.62 (CI 95%: 1.2–2.19; ) for men with KDM and 1.75 for women with KDM (CI 95%: 1.26–2.43; ), respectively. Conclusion. Current study indicates that increasing levels of altered carbohydrate metabolism are accompanied by a trend towards decreasing quality of life, mainly in women, in a representative sample of Spanish population.

1. Introduction

Diabetes mellitus is a disease that has a serious impact on the public health, owing to its high prevalence and its association with chronic complications [1].

Recently published data in our country indicate an increase in the prevalence of diabetes mellitus, so that the 13.8% of the population over 18  years of age suffers from diabetes, whereas the 30% presents either impaired fasting glucose or impaired glucose tolerance [2]. It induces a considerable economic burden for the national health system and for the society, as well as a detriment on quality of life. Its association to comorbid conditions and complications represents an opportunity to evaluate the influence of a chronic disease on health-related quality of life (HRQOL). Several studies have reported deterioration in the HRQOL of diabetic patients, particularly as far as their physical function and well-being are concerned, but also in terms of mental health [3–7]. Available data in Spain are scarce and they have been obtained in clinic-based studies or in selected populations, and the outcomes have been inconclusive [8–10]. To improve HRQOL of the diabetic patients remains as an important target of the diabetes management. Beyond development of optimal medication, treatment strategies should take HRQOL and psychosocial aspects into account.

In this study, we evaluate the association between the status in carbohydrate metabolism and HRQOL, controlled for socio-demographic and anthropometric variables, such as age, gender, body mass index (BMI), and educational level, in a large representative sample of the Spanish population. Data obtained could be useful to plan patient-based health decisions. The development of appropriate educational interventions could improve patients’ ability to control their disease, thus, resulting in an improvement in quality of life. These results should also be used as reference values to compare HRQOL in other chronic diseases and compared across countries.

2. Research Design and Methods

2.1. Population

The di@betes study is a national, cross-sectional study designed to estimate the prevalence of Diabetes mellitus in Spain. Data collection took place between 2009 and 2010.

The participants were invited to attend a single examination visit at their health centre. Information was collected using a structured, interviewer-administered questionnaire, followed by a physical examination. Fieldwork was undertaken by seven teams, comprising a nurse and dietician. After the interview, a fasting blood sample was obtained and a standard OGTT was performed. Subjects with baseline capillary blood glucose levels lower than 7.8 mmoL/L and not receiving treatment for diabetes underwent a standard OGTT, obtaining fasting and 2 h venous samples.

Of the eligible adults, 61.7% (9653) were localized, and 55.8% (5728) attended for examination. Of these, 9.9% were excluded by protocol (institutionalized, serious disease, pregnant, or recent delivery), and 5072 completed the study. Response rate of the study was a 55.8%. Differences in age and gender were not found between responders and no responders. A comprehensive description of the methodology has been previously reported [2]. People who did not complete the survey or whose data were incomplete were excluded . The present study includes 5047 subjects, aged between 18 and 90 years, who responded to the HRQOL questionnaire SF-12 (2162 men and 2885 women, with a mean age of 50.5 ± 17.3 and 50.4 ± 16.8, resp.).

2.1.1. Assessment of Quality of Life

The SF-12 (version 1), validated for use in the Spanish population, was used [7, 11, 12]. After its application by a trained interviewer, two summary scales are assessed, the PCS-12 and the MCS 12. These scales have been standardized to a mean score of 50 and a standard deviation of 10 in the general population. The MCS and PCS scores range from 0 to 100, with lower scores indicating lower HRQOL. A higher score in the respective summary scales indicates a higher quality of life [12–14]. The questionnaire was administered and supervised by a trained nutritionist (by interview).

Information regarding self-rated health was obtained from the question “Would you say that in general your health is excellent, very good, good, regular or poor?”, which is one of the twelve items included in SF-12.

Carbohydrate status was evaluated by measuring plasma fasting glucose and/or the oral glucose tolerance test, following the 1999 WHO criteria [15]. The population was divided into the following groups: normal carbohydrate metabolism, prediabetes (impaired fasting glucose and/or impaired glucose tolerance), unknown diabetes mellitus (UNKDM), or known diabetes mellitus (KDM) (in the group of KDM the prevalence of type 1 diabetes is expected to account for only 5–10% of the sample, the same percentage described in the literature) [16].

Body mass index (BMI, kg/m²) was classified into four groups: normal weight (BMI < 25 kg/m²), overweight (BMI between 25 and 29.9 kg/m²), obesity (BMI 30–39.9 kg/m²), and morbid obesity (BMI ≥ 40 kg/m²). Educational level was estimated based on the highest degree completed and divided into four groups: no studies, elementary school, secondary school education, and university degree. The duration of diabetes mellitus was divided into 3 categories: <5 years, between 5 and 15 years, and >15 years.

The presence of chronic complications was defined as self-reported history of cardiac complications (angina pectoris or myocardial infarction), stroke or circulatory disorders of the legs.

2.2. Statistical Study

Qualitative variables were summarized by their frequency distribution as well as quantitative variables by their mean and standard deviation (mean ± SDM). To compare the continuous variables PCS 12 and MCS 12 between more than two groups, the one-way analysis of variance (ANOVA) for quantitative normally distributed variables was used. If a significant difference between the groups in ANOVA was obtained, the statistical significance of multiple comparisons was evaluated by using a Bonferroni correction method.

Associations between quality of life (PCS and MCS) and glucose metabolism status were evaluated by fitting logistic regression analysis. PCS and MCS were used as dependent variables, categorized by the sample’s median. Three models are reported: the first one shows the crude rates of association, the second one reports measurements adjusted for age, and the third one shows data adjusted for age, BMI, and educational level. The three models are stratified by gender. Moreover, the effect of gender in the association between glucose metabolism and quality of life was evaluated by introducing this term of interaction into the models.

Null hypothesis was rejected by a type I error minor than 0.05 (α < 0.05). Process and analysis of the data were performed using the Statistical Package SPSS version 15.0 for Windows (SPSS, Chicago, IL, USA).

3. Results

The PCS 12 value was 50.9 ± 8.5 and the MCS 12 was 47.6 ± 10.2 (mean ± SDM). To the question “How would you define your general health?” 2.3% of the population declared having excellent health, 9% very good, 62.5% good, 22.9% regular, and 3.3% poor health.

Men had higher scores than women in both PCS 12 (51.8 ± 7.2 versus 50.3 ± 9.2; P < 0.001) and MCS 12 (50.2 ± 8.5 versus 45.5 ± 10.8; P < 0.001).

The scores for PCS 12 and MCS 12 according to age, BMI, educational level, and status of carbohydrate metabolism, stratified by gender, are shown in Table 1.

Table 1: PCS 12 and MCS 12 scores stratified by age, BMI, educational level, and glucose metabolism status.

N
PCS 12 score
MCS 12 score

M/W
M
W
M
W

Age (years)

    18–30
305/367
54.9 ± 4.7
53.5 ± 6.5
49.5 ± 8.2
46.1 ± 9.9

    31–45
597/849
53 ± 6.1
52.9 ± 6.9
49.5 ± 8.7
45.9 ± 10.2

    46–60
575/814
51.5 ± 7.3
50.3 ± 9.2
49.7 ± 8.9
44.9 ± 11.4

    61–75
493/605
50.6 ± 7.9
47.9 ± 1
51.8 ± 8.4
45.3 ± 11.4

    76
192/250
47.7 ± 9.1
43.3 ± 11.8
51.9 ± 7.5
46.7 ± 11.2

    SS: ANOVA

NS

BMI (kg/m²)

    <25
442/1034
52.9 ± 6.9
52.8 ± 7
49.8 ± 8.9
47.2 ± 9.6

    25–29
1027/980
52.4 ± 6.6
50.6 ± 9
50.3 ± 8.2
45 ± 11.2

    30–39
638/767
50.6 ± 7.8
47.8 ± 10.3
50.5 ± 8.9
44.7 ± 11.4

    40
46/91
46.1 ± 10.2
42 ± 12
50.4 ± 9.4
40.5 ± 13.5

    SS: ANOVA

NS

Educational level

    No studies
254/404
49.8 ± 8.7
45.6 ± 10.9
50.4 ± 8.8
44.1 ± 11.9

    Elementary
755/1082
51.2 ± 7.6
49.4 ± 9.8
50.5 ± 8.9
44.8 ± 11.5

    Secondary education
815/950
52.4 ± 6.9
52.1 ± 7.6
50 ± 8.7
46.1 ± 10.1

    University degree
338/448
53.6 ± 5.3
53.2 ± 6.9
50.3 ± 7.2
47.6 ± 9.4

    SS: ANOVA

NS

Glucose metabolism status

    Normal
1501/2243
52.7 ± 6.5*
51.4 ± 8.4 #
50.2 ± 8.3
46 ± 10.6⁺

    Prediabetes
276/306
50.6 ± 8**
48.3 ± 10.1##
50.6 ± 9.1
43.7 ± 11.5

    Unknown diabetes
140/103
49.9 ± 8.4
46 ± 11.1
49.8 ± 9.3
43.7 ± 11.8

    Known diabetes
245/233
48.8 ± 8.8
44.6 ± 11.5
50.9 ± 9.3
44.5 ± 11.8

    SS: ANOVA

NS

PCS 12, the physical summary component score. MCS 12, the mental summary component score. Pre-diabetes, IFG (impaired fasting glucose) and/or ITG (impaired glucose tolerance). Results expressed as mean ± SD; M/W, (men/women); NS (nonsignificant).

SS: ANOVA evaluates intragroup differences for age, BMI, educational level, and glucose metabolism status.

*, # denote differences between normal and all of the groups (prediabetes, UKDM, and KDM).

** denote pre-diabetes versus known diabetes.

## denote pre-diabetes versus known diabetes.

+ denote normal versus pre-diabetes.

A progressive deterioration of PCS 12 was observed, as major alterations in carbohydrate metabolism appeared but differences in the mental scale were not found in men.

After adjusting for age, BMI, and educational level (using a logistic regression model), this study found that physical health was considerably lower in people with KDM (men and women) when compared to the population with a normal glucose metabolism. The odds ratio for a PCS-12 score below the median was 1.62 (CI 95%: 1.2–2.19; P < 0.002) for men with KDM and 1.75 for women with KDM (CI 95%: 1.26–2.43; P < 0.001), respectively (Table 2). Worse HRQOL was defined as having a score inferior than median value, taking in mind that no optimal cut point to differentiate between bad and good quality of life has been established for Spanish population. Median values for PCS 12 and MCS 12 were 54.46 and 50.49, respectively. No differences in mental health were found between groups.

Table 2: Odds ratios for PCS 12 and MCS 12 scores lower than the median (Model 1) adjusted for age (Model 2), and adjusted for age, educational level, and BMI, all stratified by gender (Model 3).

SCHOM
PCS 12
MCS 12

OR
95% IC
P value
OR
95% IC
P value

Model 1

    Normal
1

1

    Prediabetes

        Men
1.54
1.19–1.99
0.001
0.92
0.7–1.2
0.534

        Women
1.72
1.34–2.19
0.000
1.24
0.97–1.59
0.089

    UNKDM

        Men
1.59
1.12–2.25
0.09
1.16
0.82–1.65
0.404

        Women
2.09
1.38–3.17
0.01
1.31
0.87–1.99
0.196

    KDM

        Men
2.45
1.85–3.25
0.000
0.81
0.61–1.08
0.152

        Women
3.11
2.29–4.21
0.000
1.04
0.79–1.37
0.761

Model 2

    Normal
1

1

    Prediabetes

        Men
1.25
0.96–1.63
0.105
1.02
0.78–1.35
0.878

        Women
1.33
1.03–1.71
0.029
1.33
1.03–1.72
0.027

    UNKDM

        Men
1.23
0.86–1.77
0.251
1.32
0.92–1.89
0.135

        Women
1.46
0.95–2.23
0.085
1.46
0.96–2.23
0.080

    KDM

        Men
1.83
1.36–2.46
0.000
0.94
0.69–1.27
0.692

        Women
2.15
1.56–2.95
0.000
1.16
0.87–1.55
0.321

Model 3

    Normal
1

1

    Prediabetes

        Men
1.17
0.89–1.53
0.265
1.05
0.80–1.39
0.722

        Women
1.10
0.84–1.43
0.487
1.21
0.93–1.57
0.156

    UKDM

        Men
1.07
0.74–1.54
0.719
1.35
0.93–1.95
0.113

        Women
1.12
0.73–1.74
0.601
1.33
0.86–2.05
0.197

    KDM

        Men
1.62
1.2–2.19
0.002
0.95
0.7–1.30
0.765

        Women
1.75
1.26–2.43
0.001
1.01
0.75–1.37
0.927

PCS 12, the physical component summary score. MCS 12, the mental component summary score. SCHOM, status of the carbohydrate metabolism. “Prediabetes” includes impaired fasting glucose and impaired glucose tolerance. UNKDM, unknown diabetes mellitus. KDM, known diabetes mellitus.

There was no statistically significant interaction between gender and glucose metabolism in any of the models.

In the KDM group, we evaluated the influence of the treatment with insulin, duration of diabetes, and the presence of macrovascular complications in quality of life. PCS 12 was lower in insulin-treated patients as compared with untreated diabetic patients (42.7 ± 11.3 versus 48.2 ± 9.7; P < 0.001), in the group of patients who referred at least one chronic complication (43.2 ± 11.0 versus 47.7 ± 9.9; P < 0.001), and in diabetes of more than 15 years of duration as compared to those with <5 years length (44.7 ± 10.3 versus 48.1 ± 10.2; P < 0.04). Differences in mental scales were not found.

4. Discussion

This study estimates differences in HRQOL according to status in carbohydrate metabolism, stratified by several demographic factors, for the first time in a large and representative sample of the Spanish population.

Taking into account the influence of anthropometric and demographic factors, gender is one of the most important factors when studying HRQOL. As expected, women referred a poorer HRQOL than men, regardless of age range or BMI status, in both physical and mental scales. This finding is consistent with previous research [7–9, 17].

A remarkable decrease in the physical scales was observed in the older population, which could be explained by the loss of physical abilities associated with ageing. However, in the mental scales a stabilization or slight improvement was found in the elderly. It has been hypothesized that older people may achieve greater emotional control responsiveness to negative emotions. These findings are consistent with data previously reported the in Spanish population [7–9]. Body weight is one of the modifiable risk factors that could affect HRQOL. Ford et al. [18] found that physical function was more strongly affected than mental function in obese patients. Our study showed similar findings in men, although women showed deterioration in both scores, indicating once more that the way in which HRQOL is reported is highly influenced by gender.

This study found a decrease in the physical score associated with more severe alterations in carbohydrate metabolism. This trend is observed in the mental sphere as well, but only in women. Unexpectedly, after adjusting for different confounding factors, no differences were found between the normal group and the UNKDM population. These data could suggest that the diagnosis of diabetes mellitus and the consequent modifications in life style and/or treatment would suppose a negative impact, modifying the perceived HRQOL of patients.

SF 12 scores previously reported in a German cohort of patients with diabetes are lower than those reported in this study [19] (MCS 12 was 45.8 ± 10.3 and PCS 12 was 38.9 ± 9.8). However, in this paper, 36.0% of the participants had one or more missing items in the SF-12 questionnaires, and to deal with the missing data, they applied a modified regression estimation method. Besides, people included in the study were older (aged 50 to 74 years) than those included in our sample. Similarly, another study [17] carried out in German population also found worse physical quality of life in diabetic population, reporting slightly lower PCS 12 values than our study, but higher MCS 12 values. Again, population in this study was older than in our study (58.8 versus 50.4 years old), fact that could explain the discordance. In addition, the questionnaire in our study was applied by a trained interviewer in order to avoid “missing values.”

According to our data, the presence of chronic complications, the treatment with insulin, and a prolonged course of the disease (over 15 years) decrease physical HRQOL in KDM. The presence of complications is probably the most important factor influencing the HRQOL of diabetic patients [20]. Duration of the disease has a variable effect and might not be such an important factor [3]. Regarding the effects of treatment, the results obtained so far are not conclusive [4, 18, 20, 21]. The present study found lower scores in the insulin-treated group. Unfortunately, multivariate analyses were not done because of small sample size.

Several studies that evaluate HRQOL in subjects with diabetes have been recently published in the Spanish population [22, 23]. In the first study [22], the variables that determined a poorer perception of HRQL among diabetic patients were female gender, older age, obesity, lack of physical exercise, coexistence of depression, and cerebrovascular diseases. The other study [23] reported that the variables associated with an increased risk of self-rated fair or poor health in diabetic patients were age 54–64 years or ≥65 years, presence of comorbidity, female sex, lower educational level, obesity, and no physical activity. Current study shows the OR for having a PCS-12 score below the median, adjusted for age, BMI, and educational level. After adjusting for all these factors, the group of KDM, both men and women, has considerably worse physical quality of life.

The present study has some limitations. Unfortunately HbA1c data were not assessed and therefore it is not possible to estimate HRQOL as a function of glycemic control.

Another possible bias is that the institutionalized population was not included in the sample. This group could have a worse health status than the noninstitutionalized one.

In summary, to our knowledge, this study is the largest report of HRQOL stratified by carbohydrate metabolism status in a representative sample of the Spanish population. It provides a comprehensive insight into objective and subjective factors that may affect HRQOL in patients with diabetes. Data obtained could be helpful in establishing health programs in diabetic populations to evaluate more precisely self-perception of health or creating educational projects to improve psychological well-being. It will also be useful for comparing data obtained from patients with other chronic diseases and across countries.

Authors’ Contributions

All the authors contributed to the interpretation of data, discussion of results, and critical review, and they gave final approval of the last version to be published. None declare duality of interests associated with the paper.

Acknowledgments

The authors wish to acknowledge the kind collaboration of the following entities: The Spanish Diabetes Society, the Spanish Diabetes Federation, and the Ministry of Health Quality Agency. The autjors’ profound appreciation goes to the primary care managers and personnel of the participating health centers, as well as to Dr. Luis Forga and Dr. Felipe Casanueva for their inestimable help in the management of the Northern zone. Thanks to all the field workers, nurses, and dieticians (I. Alonso, A. Arocas, R. Badia, C. M. Bixquert, N. Brito, D. Chaves, A. Cobo, L. Esquius, I Guillén, E. Mañas, A. M. Megido, N. Ojeda, R. M. Suarep, and M. D. Zomeño), without their work the study would not have been possible to carry out and to all the people who voluntarily participated in the study.

References

J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010.

F. Soriguer, A. Goday, A. Boch et al., et al., “Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study,” Diabetologia, vol. 55, pp. 88–93, 2012.

A. L. Stewart, S. Greenfield, R. D. Hays et al., “Functional status and well-being of patients with chronic study. Results from the medical outcomes study,” Journal of the American Medical Association, vol. 262, no. 7, pp. 907–913, 1989.

R. R. Rubin and M. Peyrot, “Quality of life and diabetes,” Diabetes/Metabolism Research and Reviews, vol. 15, pp. 205–218, 1999.

D. J. Wexler, R. W. Grant, E. Wittenberg et al., “Correlates of health-related quality of life in type 2 diabetes,” Diabetologia, vol. 49, no. 7, pp. 1489–1497, 2006.

P. W. Sullivan, V. Ghushchyan, H. R. Wyatt, E. Q. Wu, and J. O. Hill, “Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S,” Obesity, vol. 15, no. 2, pp. 511–521, 2007.

S. Ali, M. Stone, T. C. Skinner, N. Robertson, M. Davies, and K. Khunti, “The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 2, pp. 75–89, 2010.

G. Vilagut, J. M. Valderas, M. Ferrer, O. Garin, E. López-García, and J. Alonso, “Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components,” Medicina Clinica, vol. 130, no. 19, pp. 726–735, 2008.

G. Vilagut, M. Ferrer, L. Rajmil et al., “The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments,” Gaceta Sanitaria, vol. 19, no. 2, pp. 135–150, 2005.

E. López-García, J. R. Banegas, A. G. Pérez-Regadera, J. L. Gutiérrez-Fisac, J. Alonso, and F. Rodríguez-Artalejo, “Population-based reference values for the Spanish version of the SF-36 Health Survey in the elderly,” Medicina Clinica, vol. 120, no. 15, pp. 568–573, 2003.

B. Gandek, J. E. Ware, N. K. Aaronson et al., “Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project,” Journal of Clinical Epidemiology, vol. 51, no. 11, pp. 1171–1178, 1998.

“Normas poblacionales de referencia de la versión española del SF 12 versión 1,” Instituto Municipal de Investigación Médica, Barcelona, Spain, http://iryss.imim.es/iryss/BiblioPRO.asp

J. E. Ware, M. Kosinski, and S. D. Keller, “A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity,” Medical Care, vol. 34, no. 3, pp. 220–233, 1996.

J. E. Ware, M. Kosinski, and S. D. Keller, SF-12: How to score the SF-12 Physical and Mental Health Summary Scales, The Health Assessment Lab, Boston, Mass, USA; Quality Metric, Lincoln, RI, USA, 3rd edition, 1998.

WHO Consultation, “Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus,” Report of a WHO Consultation, World Health Organization, Geneva, Switzerland, 1999.

American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 31, supplement 1, pp. S55–S60, 2008.

M. Schunk, P. Reitmeir, S. Schipf et al., “Health-related quality of life in subjects with and without type 2 diabetes: pooled analysis of five population-based surveys in Germany,” Diabetic Medicine, vol. 29, no. 5, pp. 646–653, 2012.

E. S. Ford, D. G. Moriarty, M. M. Zack, A. H. Mokdad, and D. P. Chapman, “Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System,” Obesity Research, vol. 9, no. 1, pp. 21–31, 2001.

I. Maatouk, B. Wild, D. Wesche et al., “Temporal predictors of health-related quality of life in elderly people with diabetes: results of a German cohort study,” PLoS ONE, vol. 7, Article ID e31088, 2012.

Z. Mehta, C. Cull, I. Stratton et al., “Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37),” Diabetes Care, vol. 22, no. 7, pp. 1125–1136, 1999.

C. Bradley and J. Speight, “Patient perceptions of diabetes and diabetes therapy: assessing quality of life,” Diabetes/Metabolism Research and Reviews, vol. 18, supplement 3, pp. S64–S69, 2002.

M. M. Esteban y Peña, V. Hernandez Barrera, X. Fernández Cordero et al., “Self-perception of health status, mental health and quality of life among adults with diabetes residing in a metropolitan area,” Diabetes and Metabolism, vol. 36, no. 4, pp. 305–311, 2010.

R. Jiménez-Garcia, I. Jiménez-Trujillo, V. Hernandez-Barrera, P. Carrasco-Garrido, A. Lopez, and G. Angel, “Ten-year trends in self-rated health among Spanish adults with diabetes, 1993–2003,” Diabetes Care, vol. 31, no. 1, pp. 90–92, 2008.